Next Financial Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Next Financial Group’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-500	Closed	-$10K	–	3042
2021 Q3	$10K	Hold	500	–	–	﹤0.01%	2044
2021 Q2	$19K	Hold	500	–	–	﹤0.01%	1779
2021 Q1	$13K	Hold	500	–	–	﹤0.01%	1813
2020 Q4	$11K	Hold	500	–	–	﹤0.01%	1769
2020 Q3	$9K	Buy	+500	New	+$10.4K	﹤0.01%	1672
2020 Q2	–	Sell	-500	Closed	-$9K	–	2076
2020 Q1	$9K	Hold	500	–	–	﹤0.01%	1575
2019 Q4	$11K	Hold	500	–	–	﹤0.01%	1752
2019 Q3	$7K	Buy	+500	New	+$7.15K	﹤0.01%	1840

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Next Financial Group's DRNA Position: Q4 2021 in Review

Next Financial Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 500 shares — an estimated $10K sold.

Next Financial Group first reported a position in DRNA in Q3 2019 and held it in 8 quarters. The position peaked at $19K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Next Financial Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Next Financial Group sold 500 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $10K.
Next Financial Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2019 and held it in 8 quarters.
Next Financial Group's Dicerna Pharmaceuticals, Inc. position peaked at $19K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.